Skip to main content

Table 1 Baseline characteristics

From: Proposal for the use of echocardiography in bloodstream infections due to different streptococcal species

  Low-risk Streptococci
(n = 3230)
Moderate-risk streptococci
(n = 2106)
High-risk streptococci
(n = 556)
Very high-risk streptococci
(n = 501)
All BSIs
(N = 6393)
Demographics
 Age, mean (SD) 66.8 (16.5) 69.4 (15.6) 67.0 (17.1) 72.2 (14.2) 68.1 (16.2)
 Male, n (%) 1543 (47.8) 1204 (57.2) 325 (58.5) 301 (60.1) 3373 (52.8)
Comorbidities a
 Native valve disease b, n (%) 97 (3.0) 106 (5.0) 38 (6.8) 66 (13.2) 307 (4.8)
 Prosthetic valve, n (%) 47 (1.5) 61 (2.9) 28 (5.0) 62 (12.4) 198 (3.1)
 Previous IE, n (%) 23 (0.7) 34 (1.6) 12 (2.2) 22 (4.4) 91 (1.4)
 Cardiac device c, n (%) 120 (3.7) 101 (4.8) 26 (4.7) 46 (9.2) 293 (4.6)
 IHD, n (%) 478 (14.8) 428 (20.3) 128 (23.0) 138 (27.5) 1172 (18.3)
 CHF, n (%) 365 (11.3) 347 (16.5) 89 (16.0) 123 (24.6) 924 (14.5)
 Cancer, n (%) 787 (24.4) 671 (31.9) 162 (29.1) 130 (25.9) 1750 (27.4)
 COPD, n (%) 612 (18.9) 280 (13.3) 105 (18.9) 86 (17.2) 1083 (16.9)
 DM, n (%) 386 (12.0) 372 (17.7) 84 (15.1) 101 (20.2) 943 (14.8)
 Renal disease, n (%) 230 (7.1) 209 (9.9) 64 (11.5) 57 (11.4) 560 (8.8)
 Renal dialysis, n (%) 44 (1.4) 40 (1.9) 13 (2.3) 15 (3.0) 112 (1.8)
  1. BSI Bloodstream infection, CHF Congestive heart failure, COPD Chronic obstructive pulmonary disease, DM Diabetes mellitus, IE Infective endocarditis, IHD Ischemic heart disease
  2. a medical history prior to IE, b Native valve disease without prosthetic valve, c cardiac implantable electronic device